Navigation Links
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
Date:12/3/2008

and advancing our preclinical pipeline, while maintaining a strong balance sheet. We have established important commercial agreements in the non-therapeutic aspects of our technology with Dow Agrosciences in plant agriculture and Sigma-Aldrich Corporation in research reagents. We also have agreements with Genentech and Pfizer in cell-line engineering. We plan to establish strategic partnerships around our therapeutic programs at points of value inflection and expect 2009 to be another year of significant accomplishments for Sangamo."

Mr. Lanphier continued, "We are pursuing a broad development program for our lead ZFP Therapeutic(TM), SB-509, an activator of vascular endothelial growth factor (VEGF) with three Phase 2 clinical trials ongoing for the treatment of diabetic neuropathy (DN) and one to evaluate its use in the treatment of amyotrophic lateral sclerosis (ALS). We have also advanced our preclinical pipeline and expect to file Investigational New Drug (IND) application for the first of our ZFN-based therapeutic programs for HIV/AIDS before the end of 2008.

"We are very pleased by the progress of our non-therapeutic collaborations this year. Our partner Sigma-Aldrich successfully launched the CompoZr brand of ZFN-based gene editing tools and we look forward to the increased interest and further validation of the technology that this broadening of the user-base will bring. We also transitioned ahead of schedule into the commercial phase of our collaboration with Dow AgroSciences (DAS) to apply our ZFP technology for plant agriculture and expect DAS to begin to sublicense the technology in that industry. The success of these activities is key to further enhancing the market-leading presence for our technology. We believe that our progress in advancing our technology platform, which is unique in its generation of novel, highly differentiated therapies and products, will create interest among potential pharmace
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
2. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
7. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
8. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... de mayo de 2015 Dipexium ... compañía farmacéutica de fase tardía centrada en ... cream 0.8%), y colaboradores de investigación clínica, ... destacando el diseño innovador de los ensayos ... que evalúan Locilex®, su nuevo péptido de ...
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... clinical grade hypothermic storage and cryopreservation freeze ... cells and tissues ("BioLife" or the "Company"), announced that the ... Conference. The Company is scheduled to present ... 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... YORK , May 22, 2015 ... of the $13 billion global cardiac rhythm management ... Information.  Kalorama found that Medtronic, St. Jude Medical, ... command 80% of this market segment. The healthcare ... Device Markets , uses 2015 as a base ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
... leader in organ-specific molecular imaging, announced today that it ... scanner and PET-guided biopsy accessory.  The breast application of ... expanded its distribution into 13 European countries and has ... Switzerland. Naviscan manufactures the only ...
... PHILADELPHIA, Sept. 8, 2011 A proposed bill in ... shot" local pharmacies need to compete with mail order ... prescriptions filled by either mail-order or their community pharmacist ... keeping billions of dollars in Pennsylvania, while saving and ...
Cached Medicine Technology:Naviscan Receives CE Mark Approval for High-Resolution Breast PET and PET-Guided Biopsy 2"Prescription for Choice" Easy Pill to Swallow for Pennsylvania 2"Prescription for Choice" Easy Pill to Swallow for Pennsylvania 3
(Date:5/24/2015)... May 24, 2015 ProPin is a ... Cut Pro X. Utilize ProPin to pin point locations on ... scene. , ProPin allows users to choose from 30 ... FCPX. With on-screen controls, video editors can easily manipulate ProPin ... pin and mark with absolute ease. , Using ProPin is easy, ...
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Jay Krihak as its head of programmatic strategy ... its expertise and leadership position in the data ... sectors. , Krihak is an experienced, award-winning agency ... led sales planning teams for mobile platform Jumptap. ...
(Date:5/24/2015)... 24, 2015 A report out ... the single best option for avoiding cardiovascular disease is ... level was the single most powerful predictor of death ... as diabetes and family history of premature death -- ... heart and lung fitness. , The Importance of Cardiovascular ...
(Date:5/23/2015)... Washington, D.C. (PRWEB) May 23, 2015 ... demonstration of powers of a youngster's yogic power learned ... by Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, ... of more than 50 high profile professionals attending the ... D.C. by reading fluently -- blindfolded. , In ...
(Date:5/23/2015)... May 23, 2015 With the implementation ... are finding it increasingly difficult to provide their employees ... to provide adequate insurance for employees stand to face ... such an integral part of a business’s success or ... for businesses, Online USA Doctors has created a varying ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3
... biologists have published a paper on how cells make specific ... learning more about human developmental disorders -- in the Aug. ... Academy of Sciences . Dietmar Schreiner, postdoctoral researcher, and ... College of Liberal Arts and Sciences Department of Biology, write ...
... impossible to achieve because some body areas are much more ... Researchers - funded by the Medical Research Council (MRC) - ... some holidaymakers find it so hard to achieve an even ... the journal Experimental Dermatology , show that the buttock ...
... Epidemiology Center at Boston University School of Medicine (BUSM) ... contraceptives have a greater likelihood of developing breast cancer ... in Cancer Epidemiology Biomarkers and Prevention , were ... (BWHS), a large follow-up study of 59,000 African American ...
... impact on the food you eat, the clothes you wear, ... a special section on Culture and Psychology in Perspectives ... Psychological Science, psychological scientists Denise C. Park from the University ... of Illinois at Urbana-Champaign discuss ways in which brain structure ...
... August 3, 2010 -- As the acute phase of ... marked by long-term challenges to the public health, environment ... Disaster Preparedness interviewed over 1,200 adults living within 10 ... in collaboration with the Children,s Health Fund and The ...
... (ASP) has announced the ninth class of T. Franklin ... previous T. Franklin Williams Scholars in working to achieve ... medicine subspecialists to care for the aging population. ... development awards funded by generous grants from the Atlantic ...
Cached Medicine News:Health News:U. Iowa biologists publish findings on cell interactions 2Health News:All-over tan is a myth, study finds 2Health News:Oral contraceptive use associated with increased risk of breast cancer 2Health News:Culture wires the brain: A cognitive neuroscience perspective 2Health News:Survey of coastal residents shows Gulf oil spill has significant impact on families 2Health News:Survey of coastal residents shows Gulf oil spill has significant impact on families 3Health News:ASP announces 2010 T. Franklin Williams Scholars 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: